| 0 |
NEONATAL PNEUMOTHORAX |
18 |
0.3273 |
| 1 |
PULMONARY HAEMORRHAGE NEONATAL |
28 |
0.3043 |
| 2 |
RESPIRATORY TRACT HAEMORRHAGE NEONATAL |
2 |
0.2857 |
| 3 |
BLOODY AIRWAY DISCHARGE |
4 |
0.2500 |
| 4 |
CARDIO-RESPIRATORY ARREST NEONATAL |
12 |
0.1538 |
| 5 |
NEONATAL HYPOXIA |
126 |
0.1524 |
| 6 |
NEONATAL INTESTINAL PERFORATION |
5 |
0.1389 |
| 7 |
ENDOTRACHEAL INTUBATION COMPLICATION |
80 |
0.1356 |
| 8 |
PANTOEA AGGLOMERANS TEST POSITIVE |
1 |
0.1250 |
| 9 |
PULMONARY INTERSTITIAL EMPHYSEMA SYNDROME |
12 |
0.0845 |
| 10 |
DIVERTICULAR HERNIA |
1 |
0.0667 |
| 11 |
NEONATAL RESPIRATORY FAILURE |
33 |
0.0652 |
| 12 |
END-TIDAL CO2 DECREASED |
3 |
0.0638 |
| 13 |
HAEMORRHAGE NEONATAL |
3 |
0.0577 |
| 14 |
MENINGITIS NEONATAL |
3 |
0.0545 |
| 15 |
NEURODEVELOPMENTAL DISORDER |
36 |
0.0533 |
| 16 |
NEONATAL PNEUMONIA |
12 |
0.0511 |
| 17 |
PREMATURE BABY DEATH |
4 |
0.0488 |
| 18 |
BRONCHITIS PNEUMOCOCCAL |
1 |
0.0476 |
| 19 |
BRADYCARDIA NEONATAL |
58 |
0.0461 |
| 20 |
LISTERIA TEST POSITIVE |
1 |
0.0455 |
| 21 |
INTRAVENTRICULAR HAEMORRHAGE NEONATAL |
22 |
0.0453 |
| 22 |
LATE METABOLIC ACIDOSIS OF NEWBORN |
1 |
0.0417 |
| 23 |
CYANOSIS NEONATAL |
26 |
0.0406 |
| 24 |
MECONIUM PERITONITIS |
1 |
0.0400 |
| 25 |
AIRWAY PEAK PRESSURE INCREASED |
6 |
0.0395 |
| 26 |
CONGENITAL EMPHYSEMA |
1 |
0.0385 |
| 27 |
SCLEREMA |
3 |
0.0370 |
| 28 |
INFANTILE APNOEA |
30 |
0.0368 |
| 29 |
CARDIAC ARREST NEONATAL |
5 |
0.0362 |
| 30 |
DRUG-DEVICE INTERACTION |
4 |
0.0360 |
| 31 |
DISSEMINATED INTRAVASCULAR COAGULATION IN NEWBORN |
1 |
0.0323 |
| 32 |
NEONATAL ANURIA |
3 |
0.0316 |
| 33 |
STREPTOCOCCAL IDENTIFICATION TEST POSITIVE |
1 |
0.0303 |
| 34 |
NECROTISING ENTEROCOLITIS NEONATAL |
12 |
0.0296 |
| 35 |
BRONCHOPULMONARY DYSPLASIA |
23 |
0.0286 |
| 36 |
ENTERITIS NECROTICANS |
1 |
0.0278 |
| 37 |
RENAL FAILURE NEONATAL |
6 |
0.0270 |
| 38 |
PULMONARY HAEMORRHAGE |
207 |
0.0264 |
| 39 |
SEPSIS NEONATAL |
20 |
0.0246 |
| 40 |
PATENT DUCTUS ARTERIOSUS REPAIR |
1 |
0.0208 |
| 41 |
TRACHEAL INJURY |
3 |
0.0204 |
| 42 |
NEONATAL MULTI-ORGAN FAILURE |
1 |
0.0200 |
| 43 |
NEONATAL RESPIRATORY ACIDOSIS |
3 |
0.0197 |
| 44 |
TRAUMATIC DELIVERY |
1 |
0.0196 |
| 45 |
BASE EXCESS NEGATIVE |
1 |
0.0189 |
| 46 |
DEATH NEONATAL |
26 |
0.0187 |
| 47 |
BREATH SOUNDS ABSENT |
2 |
0.0182 |
| 48 |
NEONATAL HEPATOMEGALY |
1 |
0.0179 |
| 49 |
HYPOXIC ISCHAEMIC ENCEPHALOPATHY NEONATAL |
1 |
0.0179 |
| 50 |
BRONCHIAL INJURY |
1 |
0.0172 |
| 51 |
POSTHAEMORRHAGIC HYDROCEPHALUS |
1 |
0.0172 |
| 52 |
CIRCULATORY FAILURE NEONATAL |
1 |
0.0169 |
| 53 |
RENAL INTERSTITIAL FIBROSIS |
1 |
0.0169 |
| 54 |
ANAEMIA NEONATAL |
8 |
0.0166 |
| 55 |
NEONATAL DISORDER |
26 |
0.0164 |
| 56 |
NEONATAL HYPOTENSION |
6 |
0.0163 |
| 57 |
CHEST WALL RIGIDITY |
1 |
0.0156 |
| 58 |
CENTRAL NERVOUS SYSTEM INJURY |
1 |
0.0154 |
| 59 |
CEREBRAL HAEMORRHAGE NEONATAL |
3 |
0.0142 |
| 60 |
CYSTIC LUNG DISEASE |
2 |
0.0141 |
| 61 |
PULMONARY PNEUMATOCELE |
1 |
0.0141 |
| 62 |
MECHANICAL VENTILATION COMPLICATION |
2 |
0.0134 |
| 63 |
NEONATAL TACHYCARDIA |
2 |
0.0129 |
| 64 |
PNEUMOPERICARDIUM |
2 |
0.0116 |
| 65 |
NEONATAL INFECTION |
4 |
0.0116 |
| 66 |
NEONATAL CARDIAC FAILURE |
1 |
0.0111 |
| 67 |
CHEST EXPANSION DECREASED |
1 |
0.0108 |
| 68 |
ACINETOBACTER BACTERAEMIA |
2 |
0.0106 |
| 69 |
PERIVENTRICULAR LEUKOMALACIA |
3 |
0.0106 |
| 70 |
CONGENITAL PNEUMONIA |
1 |
0.0105 |
| 71 |
NEONATAL DYSPNOEA |
1 |
0.0105 |
| 72 |
HYPERTENSION NEONATAL |
1 |
0.0103 |
| 73 |
NEONATAL RESPIRATORY DISTRESS SYNDROME |
36 |
0.0102 |
| 74 |
RENAL IMPAIRMENT NEONATAL |
1 |
0.0099 |
| 75 |
THROMBOCYTOPENIA NEONATAL |
4 |
0.0095 |
| 76 |
MECONIUM ASPIRATION SYNDROME |
2 |
0.0095 |
| 77 |
ATELECTASIS NEONATAL |
1 |
0.0093 |
| 78 |
NEONATAL ASPIRATION |
3 |
0.0091 |
| 79 |
VERTICAL INFECTION TRANSMISSION |
1 |
0.0088 |
| 80 |
CONTINUOUS POSITIVE AIRWAY PRESSURE |
2 |
0.0087 |
| 81 |
INFANTILE APNOEIC ATTACK |
2 |
0.0085 |
| 82 |
TRACHEAL HAEMORRHAGE |
3 |
0.0085 |
| 83 |
NEONATAL ASPHYXIA |
6 |
0.0085 |
| 84 |
PRODUCT GEL FORMATION |
1 |
0.0082 |
| 85 |
NEONATAL HYPONATRAEMIA |
1 |
0.0082 |
| 86 |
BACILLUS INFECTION |
5 |
0.0079 |
| 87 |
HYPOTHERMIA NEONATAL |
1 |
0.0070 |
| 88 |
PLACENTAL TRANSFUSION SYNDROME |
1 |
0.0069 |
| 89 |
TRACHEAL OEDEMA |
1 |
0.0068 |
| 90 |
PULMONARY AIR LEAKAGE |
1 |
0.0066 |
| 91 |
PERSISTENT FOETAL CIRCULATION |
4 |
0.0066 |
| 92 |
IMMATURE RESPIRATORY SYSTEM |
1 |
0.0064 |
| 93 |
CONGENITAL GENITAL MALFORMATION |
1 |
0.0063 |
| 94 |
ULTRASOUND ABDOMEN ABNORMAL |
1 |
0.0062 |
| 95 |
ILEAL PERFORATION |
4 |
0.0060 |
| 96 |
OXYGEN SATURATION INCREASED |
2 |
0.0059 |
| 97 |
COUNTERFEIT DRUG ADMINISTERED |
2 |
0.0058 |
| 98 |
NEAR DROWNING |
1 |
0.0057 |
| 99 |
WEANING FAILURE |
2 |
0.0055 |
| 100 |
CHEST TUBE INSERTION |
1 |
0.0053 |
| 101 |
SUBCUTANEOUS EMPHYSEMA |
5 |
0.0051 |
| 102 |
USE OF ACCESSORY RESPIRATORY MUSCLES |
2 |
0.0048 |
| 103 |
NECROTISING COLITIS |
6 |
0.0047 |
| 104 |
PNEUMOTHORAX |
75 |
0.0047 |
| 105 |
PRODUCT DEPOSIT |
7 |
0.0045 |
| 106 |
NEUTROPENIA NEONATAL |
1 |
0.0045 |
| 107 |
INTRAVENTRICULAR HAEMORRHAGE |
11 |
0.0044 |
| 108 |
RENAL CORTICAL NECROSIS |
1 |
0.0043 |
| 109 |
DEPENDENCE ON OXYGEN THERAPY |
2 |
0.0041 |
| 110 |
NEONATAL SEIZURE |
1 |
0.0040 |
| 111 |
TRACHEAL OBSTRUCTION |
1 |
0.0038 |
| 112 |
HYPERCAPNIA |
11 |
0.0036 |
| 113 |
APNOEIC ATTACK |
2 |
0.0035 |
| 114 |
NEONATAL RESPIRATORY DISTRESS |
3 |
0.0032 |
| 115 |
RESPIRATORY DISORDER NEONATAL |
5 |
0.0031 |
| 116 |
RESUSCITATION |
5 |
0.0030 |
| 117 |
FLUID REPLACEMENT |
1 |
0.0030 |
| 118 |
PULMONARY NECROSIS |
1 |
0.0029 |
| 119 |
PNEUMONITIS CHEMICAL |
1 |
0.0029 |
| 120 |
CHRONIC RESPIRATORY DISEASE |
1 |
0.0028 |
| 121 |
BRAIN MALFORMATION |
1 |
0.0028 |
| 122 |
CLONIC CONVULSION |
2 |
0.0027 |
| 123 |
OXYGEN SUPPLEMENTATION |
2 |
0.0027 |
| 124 |
MEDIASTINAL DISORDER |
1 |
0.0027 |
| 125 |
BRONCHOPLEURAL FISTULA |
1 |
0.0027 |
| 126 |
JAUNDICE NEONATAL |
5 |
0.0026 |
| 127 |
FOETAL GROWTH RETARDATION |
2 |
0.0026 |
| 128 |
NEONATAL TACHYPNOEA |
1 |
0.0024 |
| 129 |
REFLUX LARYNGITIS |
1 |
0.0023 |
| 130 |
FEEDING INTOLERANCE |
1 |
0.0022 |
| 131 |
PNEUMOMEDIASTINUM |
4 |
0.0022 |
| 132 |
CARBON DIOXIDE INCREASED |
3 |
0.0022 |
| 133 |
CENTRAL NERVOUS SYSTEM HAEMORRHAGE |
1 |
0.0021 |
| 134 |
OXYGEN CONSUMPTION INCREASED |
5 |
0.0021 |
| 135 |
PATENT DUCTUS ARTERIOSUS |
8 |
0.0020 |
| 136 |
VASCULAR CALCIFICATION |
2 |
0.0019 |
| 137 |
CORYNEBACTERIUM INFECTION |
1 |
0.0019 |
| 138 |
HYPOGLYCAEMIA NEONATAL |
3 |
0.0019 |
| 139 |
INTERLEUKIN LEVEL INCREASED |
1 |
0.0018 |
| 140 |
ENDOTRACHEAL INTUBATION |
5 |
0.0018 |
| 141 |
SUSPECTED COUNTERFEIT PRODUCT |
7 |
0.0018 |
| 142 |
BLOOD PH DECREASED |
3 |
0.0018 |
| 143 |
INCORRECT STORAGE OF DRUG |
3 |
0.0017 |
| 144 |
LARYNGEAL STENOSIS |
1 |
0.0017 |
| 145 |
RESPIRATORY TRACT HAEMORRHAGE |
1 |
0.0017 |
| 146 |
OXYGEN CONSUMPTION DECREASED |
1 |
0.0017 |
| 147 |
PNEUMOPERITONEUM |
3 |
0.0016 |
| 148 |
PRODUCT COMPLAINT |
40 |
0.0016 |
| 149 |
APGAR SCORE LOW |
2 |
0.0016 |
| 150 |
PNEUMONIA NECROTISING |
1 |
0.0015 |
| 151 |
ENTEROCOCCUS TEST POSITIVE |
1 |
0.0015 |
| 152 |
VULVAL DISORDER |
1 |
0.0015 |
| 153 |
LIQUID PRODUCT PHYSICAL ISSUE |
11 |
0.0015 |
| 154 |
FOAMING AT MOUTH |
3 |
0.0015 |
| 155 |
GLYCOSURIA |
2 |
0.0015 |
| 156 |
PNEUMOTHORAX SPONTANEOUS |
1 |
0.0015 |
| 157 |
CEREBRAL CYST |
1 |
0.0015 |
| 158 |
APNOEA |
11 |
0.0014 |
| 159 |
PCO2 INCREASED |
1 |
0.0014 |
| 160 |
ANAEMIA MACROCYTIC |
3 |
0.0014 |
| 161 |
CATHETER SITE RELATED REACTION |
1 |
0.0013 |
| 162 |
COAGULATION TEST ABNORMAL |
1 |
0.0013 |
| 163 |
HYPERTROPHIC CARDIOMYOPATHY |
2 |
0.0013 |
| 164 |
PRODUCT ADMINISTRATION ERROR |
26 |
0.0013 |
| 165 |
LABORATORY TEST INTERFERENCE |
1 |
0.0013 |
| 166 |
PULMONARY HYPOPLASIA |
1 |
0.0013 |
| 167 |
PULMONARY HYPERTENSION |
26 |
0.0012 |
| 168 |
PLACENTAL INSUFFICIENCY |
1 |
0.0012 |
| 169 |
PERFORATION |
1 |
0.0012 |
| 170 |
BACTERIAL SEPSIS |
4 |
0.0012 |
| 171 |
BRADYCARDIA FOETAL |
1 |
0.0012 |
| 172 |
OESOPHAGEAL PERFORATION |
1 |
0.0012 |
| 173 |
OESOPHAGEAL RUPTURE |
1 |
0.0012 |
| 174 |
PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL |
1 |
0.0012 |
| 175 |
BRONCHIOLITIS |
4 |
0.0011 |
| 176 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
6 |
0.0011 |
| 177 |
SMALL INTESTINAL PERFORATION |
2 |
0.0011 |
| 178 |
HEPATIC CONGESTION |
1 |
0.0011 |
| 179 |
MECHANICAL VENTILATION |
2 |
0.0011 |
| 180 |
INTUSSUSCEPTION |
1 |
0.0010 |
| 181 |
AGITATION NEONATAL |
1 |
0.0010 |
| 182 |
PRESCRIBED OVERDOSE |
20 |
0.0010 |
| 183 |
DRUG ADMINISTERED IN WRONG DEVICE |
1 |
0.0010 |
| 184 |
RESPIRATORY ACIDOSIS |
4 |
0.0010 |
| 185 |
DROWNING |
1 |
0.0010 |
| 186 |
SUSPECTED PRODUCT CONTAMINATION |
1 |
0.0010 |
| 187 |
PRODUCT COLOUR ISSUE |
5 |
0.0010 |
| 188 |
CAPILLARY LEAK SYNDROME |
2 |
0.0010 |
| 189 |
HYPOPERFUSION |
1 |
0.0010 |
| 190 |
OXYGEN SATURATION DECREASED |
52 |
0.0009 |
| 191 |
HYPOVENTILATION |
3 |
0.0009 |
| 192 |
ACINETOBACTER INFECTION |
1 |
0.0009 |
| 193 |
PRODUCT SELECTION ERROR |
1 |
0.0009 |
| 194 |
KLEBSIELLA SEPSIS |
1 |
0.0009 |
| 195 |
CENTRAL NERVOUS SYSTEM INFECTION |
1 |
0.0009 |
| 196 |
HYPOCHLORAEMIA |
1 |
0.0009 |
| 197 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
15 |
0.0008 |
| 198 |
LABILE BLOOD PRESSURE |
1 |
0.0008 |
| 199 |
ILL-DEFINED DISORDER |
50 |
0.0008 |
| 200 |
TUBERCULIN TEST POSITIVE |
2 |
0.0008 |
| 201 |
INCREASED BRONCHIAL SECRETION |
2 |
0.0008 |
| 202 |
LUNG OPACITY |
2 |
0.0008 |
| 203 |
OBSTRUCTION |
3 |
0.0008 |
| 204 |
OFF LABEL USE OF DEVICE |
1 |
0.0007 |
| 205 |
MUCOUS MEMBRANE DISORDER |
1 |
0.0007 |
| 206 |
OXYGEN SATURATION ABNORMAL |
2 |
0.0007 |
| 207 |
CONNECTIVE TISSUE DISORDER |
1 |
0.0007 |
| 208 |
RENAL INFARCT |
1 |
0.0007 |
| 209 |
BLOOD PRESSURE IMMEASURABLE |
1 |
0.0007 |
| 210 |
BRONCHIAL DISORDER |
1 |
0.0006 |
| 211 |
HYPOTONIA NEONATAL |
1 |
0.0006 |
| 212 |
DEVICE OCCLUSION |
9 |
0.0006 |
| 213 |
DISSEMINATED INTRAVASCULAR COAGULATION |
9 |
0.0006 |
| 214 |
GASTROINTESTINAL STOMA COMPLICATION |
1 |
0.0006 |
| 215 |
CYANOSIS |
10 |
0.0006 |
| 216 |
FUNGAEMIA |
1 |
0.0006 |
| 217 |
INTESTINAL PERFORATION |
7 |
0.0006 |
| 218 |
METABOLIC SYNDROME |
1 |
0.0006 |
| 219 |
BRADYARRHYTHMIA |
1 |
0.0006 |
| 220 |
PRODUCT COUNTERFEIT |
1 |
0.0006 |
| 221 |
PSEUDOMONAL SEPSIS |
1 |
0.0006 |
| 222 |
CONDUCTION DISORDER |
1 |
0.0005 |
| 223 |
BRADYCARDIA |
28 |
0.0005 |
| 224 |
HYPOPROTEINAEMIA |
1 |
0.0005 |
| 225 |
ADRENAL DISORDER |
1 |
0.0005 |
| 226 |
CARDIOPULMONARY FAILURE |
2 |
0.0005 |
| 227 |
HYPERTRIGLYCERIDAEMIA |
3 |
0.0005 |
| 228 |
GENE MUTATION |
1 |
0.0005 |
| 229 |
EMPYEMA |
1 |
0.0005 |
| 230 |
PREMATURE BABY |
15 |
0.0005 |
| 231 |
HYPOSPADIAS |
1 |
0.0005 |
| 232 |
DILATATION VENTRICULAR |
1 |
0.0005 |
| 233 |
NOSOCOMIAL INFECTION |
1 |
0.0005 |
| 234 |
TEMPERATURE REGULATION DISORDER |
1 |
0.0004 |
| 235 |
PRODUCT PACKAGE ASSOCIATED INJURY |
1 |
0.0004 |
| 236 |
CALCINOSIS |
1 |
0.0004 |
| 237 |
GASTROINTESTINAL HYPOMOTILITY |
1 |
0.0004 |
| 238 |
DRUG ADMINISTRATION ERROR |
13 |
0.0004 |
| 239 |
NO THERAPEUTIC RESPONSE |
5 |
0.0004 |
| 240 |
DRUG EFFECT LESS THAN EXPECTED |
6 |
0.0004 |
| 241 |
SMALL FOR DATES BABY |
2 |
0.0004 |
| 242 |
HYPERNATRAEMIA |
2 |
0.0004 |
| 243 |
CATHETER SITE HAEMORRHAGE |
1 |
0.0004 |
| 244 |
EXCORIATION |
1 |
0.0004 |
| 245 |
SHOCK |
9 |
0.0004 |
| 246 |
MATERNAL DRUGS AFFECTING FOETUS |
3 |
0.0004 |
| 247 |
VENTRICULAR DYSFUNCTION |
1 |
0.0004 |
| 248 |
MUCORMYCOSIS |
1 |
0.0004 |
| 249 |
LOW BIRTH WEIGHT BABY |
3 |
0.0004 |
| 250 |
INTESTINAL ISCHAEMIA |
2 |
0.0004 |
| 251 |
NECROSIS |
2 |
0.0004 |
| 252 |
CIRCULATORY COLLAPSE |
6 |
0.0004 |
| 253 |
HAEMOTHORAX |
1 |
0.0003 |
| 254 |
ELECTROLYTE IMBALANCE |
4 |
0.0003 |
| 255 |
GASTROINTESTINAL NECROSIS |
1 |
0.0003 |
| 256 |
RESPIRATORY FAILURE |
25 |
0.0003 |
| 257 |
PULMONARY PAIN |
1 |
0.0003 |
| 258 |
STRIDOR |
1 |
0.0003 |
| 259 |
CARDIO-RESPIRATORY ARREST |
14 |
0.0003 |
| 260 |
CENTRAL VENOUS CATHETERISATION |
1 |
0.0003 |
| 261 |
RESPIRATORY DISTRESS |
9 |
0.0003 |
| 262 |
ELECTROENCEPHALOGRAM ABNORMAL |
1 |
0.0003 |
| 263 |
HEART RATE DECREASED |
11 |
0.0003 |
| 264 |
METABOLIC ACIDOSIS |
10 |
0.0003 |
| 265 |
INCORRECT PRODUCT STORAGE |
4 |
0.0003 |
| 266 |
SKIN INJURY |
1 |
0.0003 |
| 267 |
HYPOTONIA |
3 |
0.0003 |
| 268 |
ECCHYMOSIS |
2 |
0.0003 |
| 269 |
REGURGITATION |
1 |
0.0003 |
| 270 |
HEART DISEASE CONGENITAL |
1 |
0.0003 |
| 271 |
PULMONARY ARTERIAL HYPERTENSION |
4 |
0.0003 |
| 272 |
OBSTRUCTIVE AIRWAYS DISORDER |
3 |
0.0003 |
| 273 |
HAEMORRHAGE INTRACRANIAL |
4 |
0.0003 |
| 274 |
FACE INJURY |
1 |
0.0003 |
| 275 |
HAEMODYNAMIC INSTABILITY |
2 |
0.0003 |
| 276 |
ACUTE RESPIRATORY FAILURE |
5 |
0.0003 |
| 277 |
PRODUCT QUALITY ISSUE |
35 |
0.0003 |
| 278 |
TRICUSPID VALVE INCOMPETENCE |
2 |
0.0003 |
| 279 |
EXPOSURE VIA BREAST MILK |
1 |
0.0003 |
| 280 |
HYPERGLYCAEMIA |
9 |
0.0002 |
| 281 |
PERITONITIS |
5 |
0.0002 |
| 282 |
COAGULOPATHY |
4 |
0.0002 |
| 283 |
INCORRECT DRUG ADMINISTRATION RATE |
1 |
0.0002 |
| 284 |
POOR PERIPHERAL CIRCULATION |
1 |
0.0002 |
| 285 |
ANURIA |
2 |
0.0002 |
| 286 |
URINE OUTPUT DECREASED |
2 |
0.0002 |
| 287 |
PULMONARY FUNCTION TEST DECREASED |
1 |
0.0002 |
| 288 |
LUNG INFILTRATION |
2 |
0.0002 |
| 289 |
TACHYPNOEA |
3 |
0.0002 |
| 290 |
UNDERDOSE |
16 |
0.0002 |
| 291 |
CARDIAC ARREST |
18 |
0.0002 |
| 292 |
ISCHAEMIA |
1 |
0.0002 |
| 293 |
BLOOD SODIUM DECREASED |
4 |
0.0002 |
| 294 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
6 |
0.0002 |
| 295 |
BRONCHOSPASM |
3 |
0.0002 |
| 296 |
SEPSIS |
23 |
0.0002 |
| 297 |
RENAL TUBULAR NECROSIS |
2 |
0.0002 |
| 298 |
APPLICATION SITE BURN |
1 |
0.0002 |
| 299 |
BREATH SOUNDS ABNORMAL |
1 |
0.0002 |
| 300 |
STAPHYLOCOCCAL SEPSIS |
1 |
0.0002 |
| 301 |
EXPIRED DRUG ADMINISTERED |
1 |
0.0002 |
| 302 |
HYPOXIA |
7 |
0.0002 |
| 303 |
EMPHYSEMA |
2 |
0.0002 |
| 304 |
PRODUCT SOLUBILITY ABNORMAL |
1 |
0.0002 |
| 305 |
KLEBSIELLA INFECTION |
1 |
0.0002 |
| 306 |
DYSPHORIA |
1 |
0.0002 |
| 307 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
1 |
0.0002 |
| 308 |
LUNG INFECTION |
3 |
0.0002 |
| 309 |
MALABSORPTION |
1 |
0.0002 |
| 310 |
DERMATITIS |
4 |
0.0002 |
| 311 |
PALLOR |
5 |
0.0002 |
| 312 |
HYDROCEPHALUS |
1 |
0.0002 |
| 313 |
ASPIRATION |
2 |
0.0002 |
| 314 |
HAEMOPTYSIS |
5 |
0.0002 |
| 315 |
ANGIOPATHY |
1 |
0.0002 |
| 316 |
VENTRICULAR SEPTAL DEFECT |
1 |
0.0002 |
| 317 |
MULTI-ORGAN FAILURE |
3 |
0.0002 |
| 318 |
ENTEROCOLITIS |
1 |
0.0002 |
| 319 |
METABOLIC DISORDER |
1 |
0.0002 |
| 320 |
RALES |
1 |
0.0002 |
| 321 |
POST PROCEDURAL HAEMORRHAGE |
2 |
0.0002 |
| 322 |
CAESAREAN SECTION |
2 |
0.0002 |
| 323 |
MUSCLE RIGIDITY |
2 |
0.0002 |
| 324 |
PROTHROMBIN TIME PROLONGED |
1 |
0.0002 |
| 325 |
FOETAL GROWTH RESTRICTION |
1 |
0.0002 |
| 326 |
PIGMENTATION DISORDER |
1 |
0.0002 |
| 327 |
GENERALISED OEDEMA |
2 |
0.0002 |
| 328 |
OLIGURIA |
1 |
0.0002 |
| 329 |
APPLICATION SITE VESICLES |
1 |
0.0002 |
| 330 |
CHOKING |
3 |
0.0002 |
| 331 |
GENERAL PHYSICAL CONDITION ABNORMAL |
1 |
0.0001 |
| 332 |
DRUG EXPOSURE DURING PREGNANCY |
5 |
0.0001 |
| 333 |
GENERAL PHYSICAL HEALTH DETERIORATION |
17 |
0.0001 |
| 334 |
PNEUMONITIS |
4 |
0.0001 |
| 335 |
RESPIRATION ABNORMAL |
1 |
0.0001 |
| 336 |
LUNG DISORDER |
7 |
0.0001 |
| 337 |
CEREBRAL HAEMORRHAGE |
5 |
0.0001 |
| 338 |
INJECTION SITE HAEMATOMA |
2 |
0.0001 |
| 339 |
PRODUCT DISPENSING ERROR |
3 |
0.0001 |
| 340 |
MOUTH HAEMORRHAGE |
1 |
0.0001 |
| 341 |
ASCITES |
4 |
0.0001 |
| 342 |
BLOOD PRESSURE DIASTOLIC DECREASED |
1 |
0.0001 |
| 343 |
HYPOPHOSPHATAEMIA |
1 |
0.0001 |
| 344 |
RESPIRATORY DISORDER |
4 |
0.0001 |
| 345 |
ACIDOSIS |
1 |
0.0001 |
| 346 |
BOWEL MOVEMENT IRREGULARITY |
1 |
0.0001 |
| 347 |
SKIN DISCOLOURATION |
6 |
0.0001 |
| 348 |
PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 349 |
ATRIOVENTRICULAR BLOCK |
1 |
0.0001 |
| 350 |
CONGENITAL ANOMALY |
1 |
0.0001 |
| 351 |
POLYURIA |
1 |
0.0001 |
| 352 |
DRUG LEVEL INCREASED |
2 |
0.0001 |
| 353 |
EXPIRED PRODUCT ADMINISTERED |
4 |
0.0001 |
| 354 |
BLOOD UREA INCREASED |
2 |
0.0001 |
| 355 |
PSEUDOMONAS INFECTION |
1 |
0.0001 |
| 356 |
RASH GENERALISED |
3 |
0.0001 |
| 357 |
HYPERKALAEMIA |
4 |
0.0001 |
| 358 |
RESPIRATORY RATE INCREASED |
1 |
0.0001 |
| 359 |
PULMONARY OEDEMA |
5 |
0.0001 |
| 360 |
HAEMOLYTIC ANAEMIA |
1 |
0.0001 |
| 361 |
HYPOCALCAEMIA |
2 |
0.0001 |
| 362 |
BLOOD PRESSURE DECREASED |
7 |
0.0001 |
| 363 |
ATELECTASIS |
1 |
0.0001 |
| 364 |
HAEMATOCRIT DECREASED |
2 |
0.0001 |
| 365 |
BRAIN INJURY |
1 |
0.0001 |
| 366 |
OFF LABEL USE |
87 |
0.0001 |
| 367 |
PERITONITIS BACTERIAL |
1 |
0.0001 |
| 368 |
HYPOTHERMIA |
1 |
0.0001 |
| 369 |
FOETAL EXPOSURE DURING PREGNANCY |
8 |
0.0001 |
| 370 |
HYPERBILIRUBINAEMIA |
1 |
0.0001 |
| 371 |
PETECHIAE |
1 |
0.0001 |
| 372 |
TRANSFUSION |
1 |
0.0001 |
| 373 |
DRUG ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
| 374 |
DECREASED ACTIVITY |
1 |
0.0001 |
| 375 |
BLOOD CREATININE INCREASED |
6 |
0.0001 |
| 376 |
INTERVERTEBRAL DISC PROTRUSION |
2 |
0.0001 |
| 377 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
6 |
0.0001 |
| 378 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
3 |
0.0001 |
| 379 |
C-REACTIVE PROTEIN INCREASED |
3 |
0.0001 |
| 380 |
RESPIRATORY DEPRESSION |
1 |
0.0001 |
| 381 |
INJECTION SITE URTICARIA |
2 |
0.0001 |
| 382 |
UNEVALUABLE EVENT |
6 |
0.0001 |
| 383 |
ANAPHYLACTIC SHOCK |
2 |
0.0001 |
| 384 |
DEATH |
65 |
0.0001 |
| 385 |
ADVERSE REACTION |
1 |
0.0001 |
| 386 |
CARDIAC FAILURE |
6 |
0.0001 |
| 387 |
BLOOD BILIRUBIN INCREASED |
2 |
0.0001 |
| 388 |
DRUG TOXICITY |
1 |
0.0001 |
| 389 |
DEVICE DELIVERY SYSTEM ISSUE |
2 |
0.0001 |
| 390 |
PERIPHERAL COLDNESS |
1 |
0.0001 |
| 391 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
13 |
0.0001 |
| 392 |
HYPOMAGNESAEMIA |
1 |
0.0001 |
| 393 |
CARDIOGENIC SHOCK |
1 |
0.0001 |
| 394 |
HYPOKINESIA |
1 |
0.0001 |
| 395 |
CARDIOMYOPATHY |
1 |
0.0001 |
| 396 |
ABDOMINAL DISTENSION |
7 |
0.0001 |
| 397 |
EJECTION FRACTION DECREASED |
1 |
0.0001 |
| 398 |
PREMATURE DELIVERY |
1 |
0.0001 |
| 399 |
DRUG INEFFECTIVE |
81 |
0.0001 |
| 400 |
VENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 401 |
CYTOMEGALOVIRUS INFECTION |
1 |
0.0001 |
| 402 |
LEUKOPENIA |
3 |
0.0001 |
| 403 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0001 |
| 404 |
TRANSIENT ISCHAEMIC ATTACK |
2 |
0.0001 |
| 405 |
CONDITION AGGRAVATED |
18 |
0.0001 |
| 406 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
0.0001 |
| 407 |
INTENTIONAL PRODUCT USE ISSUE |
5 |
0.0001 |
| 408 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
2 |
0.0001 |
| 409 |
MEDICATION ERROR |
3 |
0.0001 |
| 410 |
THROMBOCYTOPENIA |
6 |
0.0001 |
| 411 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 412 |
CONVULSION |
3 |
0.0001 |
| 413 |
PULMONARY FIBROSIS |
1 |
0.0001 |
| 414 |
CHOLESTASIS |
1 |
0.0001 |
| 415 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 416 |
OVERDOSE |
11 |
0.0001 |
| 417 |
HYPOTENSION |
10 |
0.0000 |
| 418 |
PRODUCT PHYSICAL ISSUE |
1 |
0.0000 |
| 419 |
RIB FRACTURE |
1 |
0.0000 |
| 420 |
GASTROINTESTINAL HAEMORRHAGE |
4 |
0.0000 |
| 421 |
SEPTIC SHOCK |
2 |
0.0000 |
| 422 |
GASTROINTESTINAL DISORDER |
4 |
0.0000 |
| 423 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 424 |
PERICARDIAL EFFUSION |
1 |
0.0000 |
| 425 |
ARRHYTHMIA |
2 |
0.0000 |
| 426 |
INFECTION |
6 |
0.0000 |
| 427 |
INTERSTITIAL LUNG DISEASE |
2 |
0.0000 |
| 428 |
LIVER INJURY |
1 |
0.0000 |
| 429 |
PNEUMONIA ASPIRATION |
1 |
0.0000 |
| 430 |
INJECTION SITE SWELLING |
3 |
0.0000 |
| 431 |
HAEMOGLOBIN DECREASED |
4 |
0.0000 |
| 432 |
HAEMATOMA |
1 |
0.0000 |
| 433 |
PHARMACEUTICAL PRODUCT COMPLAINT |
1 |
0.0000 |
| 434 |
ANHEDONIA |
1 |
0.0000 |
| 435 |
PRODUCT USE ISSUE |
7 |
0.0000 |
| 436 |
FEAR |
1 |
0.0000 |
| 437 |
JAUNDICE |
1 |
0.0000 |
| 438 |
PNEUMONIA |
12 |
0.0000 |
| 439 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
2 |
0.0000 |
| 440 |
RESPIRATORY ARREST |
1 |
0.0000 |
| 441 |
ANAPHYLACTIC REACTION |
2 |
0.0000 |
| 442 |
INCORRECT DRUG ADMINISTRATION DURATION |
1 |
0.0000 |
| 443 |
HYPONATRAEMIA |
2 |
0.0000 |
| 444 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
0.0000 |
| 445 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 446 |
PRODUCT STORAGE ERROR |
3 |
0.0000 |
| 447 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 448 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 449 |
RENAL INJURY |
1 |
0.0000 |
| 450 |
HEPATIC FAILURE |
1 |
0.0000 |
| 451 |
NO ADVERSE EVENT |
6 |
0.0000 |
| 452 |
ACUTE KIDNEY INJURY |
5 |
0.0000 |
| 453 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 454 |
THERAPEUTIC RESPONSE SHORTENED |
1 |
0.0000 |
| 455 |
RENAL FAILURE |
4 |
0.0000 |
| 456 |
SKIN DISORDER |
1 |
0.0000 |
| 457 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
6 |
0.0000 |
| 458 |
NEUTROPENIA |
4 |
0.0000 |
| 459 |
HAEMORRHAGE |
3 |
0.0000 |
| 460 |
DEVICE MALFUNCTION |
2 |
0.0000 |
| 461 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
2 |
0.0000 |
| 462 |
DRUG EFFECT INCOMPLETE |
1 |
0.0000 |
| 463 |
RESTLESSNESS |
1 |
0.0000 |
| 464 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 465 |
GASTROOESOPHAGEAL REFLUX DISEASE |
2 |
0.0000 |
| 466 |
RENAL IMPAIRMENT |
2 |
0.0000 |
| 467 |
RENAL FAILURE ACUTE |
1 |
0.0000 |
| 468 |
DYSPNOEA |
13 |
0.0000 |
| 469 |
DEVICE ISSUE |
2 |
0.0000 |
| 470 |
ADVERSE DRUG REACTION |
2 |
0.0000 |
| 471 |
INCORRECT DOSE ADMINISTERED |
5 |
0.0000 |
| 472 |
HYPOKALAEMIA |
1 |
0.0000 |
| 473 |
RENAL DISORDER |
1 |
0.0000 |
| 474 |
CARDIAC DISORDER |
2 |
0.0000 |
| 475 |
SWELLING |
2 |
0.0000 |
| 476 |
COMA |
1 |
0.0000 |
| 477 |
ANAEMIA |
4 |
0.0000 |
| 478 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 479 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 480 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 481 |
FLUID RETENTION |
1 |
0.0000 |
| 482 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 483 |
ERYTHEMA |
4 |
0.0000 |
| 484 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 485 |
PLATELET COUNT DECREASED |
2 |
0.0000 |
| 486 |
MALAISE |
8 |
0.0000 |
| 487 |
BLISTER |
1 |
0.0000 |
| 488 |
FLATULENCE |
1 |
0.0000 |
| 489 |
SEIZURE |
2 |
0.0000 |
| 490 |
DISEASE PROGRESSION |
2 |
0.0000 |
| 491 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 492 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 493 |
AMNESIA |
1 |
0.0000 |
| 494 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 495 |
INJURY |
1 |
0.0000 |
| 496 |
EPISTAXIS |
1 |
0.0000 |
| 497 |
THROMBOSIS |
1 |
0.0000 |
| 498 |
TREATMENT FAILURE |
1 |
0.0000 |
| 499 |
TOXICITY TO VARIOUS AGENTS |
2 |
0.0000 |
| 500 |
BALANCE DISORDER |
1 |
0.0000 |
| 501 |
DRUG WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 502 |
TACHYCARDIA |
1 |
0.0000 |
| 503 |
ADVERSE EVENT |
1 |
0.0000 |
| 504 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 505 |
HEART RATE INCREASED |
1 |
0.0000 |
| 506 |
HYPERTENSION |
2 |
0.0000 |
| 507 |
PYREXIA |
3 |
0.0000 |
| 508 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 509 |
PRODUCT USE IN UNAPPROVED INDICATION |
2 |
0.0000 |
| 510 |
DEHYDRATION |
1 |
0.0000 |
| 511 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 512 |
TREMOR |
1 |
0.0000 |
| 513 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 514 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 515 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 516 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 517 |
ALOPECIA |
1 |
0.0000 |
| 518 |
WEIGHT INCREASED |
1 |
0.0000 |
| 519 |
ANXIETY |
1 |
0.0000 |
| 520 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 521 |
PAIN |
2 |
0.0000 |
| 522 |
VOMITING |
1 |
0.0000 |
| 523 |
FATIGUE |
1 |
0.0000 |